SCHEMBL6983466

SCHEMBL6983466

COC(=O)c1ccc(CCCCCSc2nc(-c3ccccc3N3CCOCC3)cc(=O)[nH]2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.40
HDAC1 Q13547 4/20 0.39
HDAC6 Q9UBN7 4/20 0.39
ALDH1A1 P00352 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
GPR84 Q9NQS5 2/20 0.38
AKT1 P31749 4/20 0.37
POLB P06746 2/20 0.37
KDM4C Q9H3R0 1/20 0.37
EPHX2 P34913 1/20 0.37
TSHR P16473 1/20 0.36
PIK3C3 Q8NEB9 2/20 0.36
ATM Q13315 1/20 0.36
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CB P42338 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979872 0.92 GPR84 (0.42) HSD17B10HDAC1HDAC6ALDH1A1HDAC3
SCHEMBL6981656 0.87 XDH (0.44) HSD17B10HDAC1HDAC6ALDH1A1HDAC3
SCHEMBL6978040 0.82 HDAC1 (0.57) HDAC1HDAC6ALDH1A1HDAC3HDAC2
SCHEMBL6978096 0.81 HDAC1 (0.60) HDAC1HDAC6ALDH1A1HDAC3HDAC2
SCHEMBL6969616 0.79 HDAC1 (0.55) HDAC1HDAC6ALDH1A1HDAC3HDAC2
SCHEMBL6979874 0.79 XDH (0.47) HSD17B10HDAC1HDAC6ALDH1A1HDAC3
SCHEMBL6973306 0.78 HDAC1 (0.52) HDAC1HDAC6ALDH1A1HDAC3HDAC2
SCHEMBL6975058 0.77 ACMSD (0.43) HSD17B10HDAC1HDAC6ALDH1A1HDAC3
SCHEMBL6975037 0.75 HDAC1 (0.45) HDAC1HDAC6ALDH1A1HDAC3HDAC2
SCHEMBL6978480 0.74 HDAC1 (0.59) HDAC1HDAC6ALDH1A1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed